Literature DB >> 8886292

Blink rate, neurocognitive impairments, and symptoms in schizophrenia.

E Y Chen1, L C Lam, R Y Chen, D G Nguyen.   

Abstract

This study addresses the relationship between blink rate (as a measure of central dopaminergic activity), symptoms, neuropsychological performance, as well as neurological signs in schizophrenia. Blink rate between schizophrenic patients and a matched control group was compared in both "relaxed" and "attentive" conditions. Blink rate was increased in schizophrenic patients in the "relaxed" condition but not in the "attentive" condition. The relationship between blink rate and clinical variables was examined in a larger sample of 204 patients. In both "relaxed" and "attentive" conditions, blink rate was related to "hallucinations," "anxiety," negative symptoms, and neuroleptic dosage. Attention was a significant predictor only in the "relaxed" condition. No other significant correlation was found between blink rate, neuropsychological impairments, and neurological signs. These findings suggest that blink rate is not related to neurocognitive impairments in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886292     DOI: 10.1016/0006-3223(95)00482-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  10 in total

1.  Spontaneous Eye-Blink Rate as an Index of Reward Responsivity: Validation and Links to Bipolar Disorder.

Authors:  Andrew D Peckham; Sheri L Johnson
Journal:  Clin Psychol Sci       Date:  2015-09-03

2.  Preliminary effects of prefrontal tDCS on dopamine-mediated behavior and psychophysiology.

Authors:  Michael J Imburgio; Hannah K Ballard; Astin C Cornwall; Darrell A Worthy; Jessica A Bernard; Joseph M Orr
Journal:  Behav Brain Res       Date:  2021-01-10       Impact factor: 3.332

Review 3.  An Overview of the Association between Schizotypy and Dopamine.

Authors:  Christine Mohr; Ulrich Ettinger
Journal:  Front Psychiatry       Date:  2014-12-19       Impact factor: 4.157

4.  Spontaneous Eye Blink Rate (EBR) Is Uncorrelated with Dopamine D2 Receptor Availability and Unmodulated by Dopamine Agonism in Healthy Adults.

Authors:  Linh C Dang; Gregory R Samanez-Larkin; Jaime J Castrellon; Scott F Perkins; Ronald L Cowan; Paul A Newhouse; David H Zald
Journal:  eNeuro       Date:  2017-09-18

5.  Interactive Effects of Dopamine Baseline Levels and Cycle Phase on Executive Functions: The Role of Progesterone.

Authors:  Esmeralda Hidalgo-Lopez; Belinda Pletzer
Journal:  Front Neurosci       Date:  2017-07-13       Impact factor: 4.677

6.  Spontaneous eye blink rate and dopamine synthesis capacity: preliminary evidence for an absence of positive correlation.

Authors:  Guillaume Sescousse; Romain Ligneul; Ruth J van Holst; Lieneke K Janssen; Femke de Boer; Marcel Janssen; Anne S Berry; William J Jagust; Roshan Cools
Journal:  Eur J Neurosci       Date:  2018-03-26       Impact factor: 3.386

7.  Effect of distance vision and refractive error on the spontaneous eye blink activity in human subjects in primary eye gaze.

Authors:  Michael J Doughty
Journal:  J Optom       Date:  2018-04-05

8.  Blink rate is associated with drug-induced parkinsonism in patients with severe mental illness, but does not meet requirements to serve as a clinical test: the Curacao extrapyramidal syndromes study XIII.

Authors:  Charlotte L Mentzel; P Roberto Bakker; Jim van Os; Marjan Drukker; Glenn E Matroos; Marina A J Tijssen; Peter N van Harten
Journal:  J Negat Results Biomed       Date:  2017-08-25

9.  Striatal D1 and D2 receptor availability are selectively associated with eye-blink rates after methylphenidate treatment.

Authors:  Şükrü B Demiral; Peter Manza; Erin Biesecker; Corinde Wiers; Ehsan Shokri-Kojori; Katherine McPherson; Evan Dennis; Allison Johnson; Dardo Tomasi; Gene-Jack Wang; Nora D Volkow
Journal:  Commun Biol       Date:  2022-09-26

10.  Intra-subject consistency of spontaneous eye blink rate in young women across the menstrual cycle.

Authors:  Esmeralda Hidalgo-Lopez; Georg Zimmermann; Belinda Pletzer
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.